2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) - Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; et al. (European heart journal, 2022)
Keywords: Antineoplastic Agents - therapeutic use; Heart; Hematology; Humans; Life Sciences; Medical Oncology; Neoplasms - drug therapy; Radiation Oncology; Hormone therapy; Cardiac tumour; Carcinoid syndrome; Guidelines; Cancer survivors; Immunotherapy; Risk stratification; QTc prolongation; Venous thromboembolism; Fluoropyrimidine; Heart failure; Hypertension; Androgen deprivation therapy; Echocardiography; Atrial fibrillation; Cardiotoxicity; Haematopoietic stem cell transplantation; Radiotherapy; Coronary artery disease; Thrombosis; Proteasome inhibitors; Pulmonary hypertension; Strain; Myocarditis; Valvular heart disease; Chemotherapy; Anthracycline; Vascular endothelial growth factor inhibitors (VEGFi); Cardiac magnetic resonance; Biomarkers; Cardio-oncology; Pericardial disease; Amyloid light-chain cardiac amyloidosis; Ischaemic heart disease; Arrhythmias; Trastuzumab; Cancer